文献速递心力衰竭与心肌病血脂与心血管预防

心脏影像学在肿瘤心脏病学中的应用:心脏毒性的检测

Cardiac imaging in oncology: the detection of cardiotoxicity.
PubMed 文献 · Heart · 2025-10-29

本文综述了肿瘤心脏病学中心脏毒性(癌症治疗相关心血管毒性,CTR-CVT)的影像学检测工具与策略,涵盖常规与新兴影像模态,强调早期发现对避免不可逆心脏损伤和维持生活质量的关键作用,并讨论了各模态的优势、局限及不断演变的指南。

要点

  • 心脏毒性涵盖从无症状左室收缩功能障碍到心衰、心肌炎、心律失常及缺血事件。
  • 早期检测心脏毒性对预防不可逆心脏损伤和维持生活质量至关重要。
  • 超声心动图在监测、检测和管理癌症患者心功能障碍中起核心作用。

核心结论

  • 心脏影像学尤其是超声心动图在检测癌症治疗相关心血管毒性中起关键作用。
  • 早期发现心脏毒性可及时调整抗癌治疗或启动心脏保护策略以阻止或逆转心脏损伤。

研究设计与样本

  • 综述,聚焦肿瘤心脏病学中检测心脏毒性的影像工具与策略。

主要发现

  • CTR-CVT涵盖从无症状左室收缩功能障碍到危及生命的心衰、心肌炎、心律失常及缺血事件。
  • 癌症幸存者中心血管疾病已成为主要致病和致死原因之一,需在治疗前、中、后警惕监测。

临床怎么用

  • 临床应利用影像学工具在抗癌治疗前、中、后监测心脏功能以及时发现心脏毒性。
  • 早期识别心脏毒性后可通过调整抗癌方案或实施心脏保护策略来阻止或逆转心脏损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardio-oncology has emerged as a rapidly growing subspecialty within both cardiology and oncology, bridging the gap between these two disciplines to address the cardiovascular complications associated with cancer therapies. The development of novel therapies and targeted agents has revolutionised cancer treatment and patient survival. However, these advances have been accompanied by an increase in cardiovascular complications, commonly referred to simply as 'cardiotoxicity', or more recently, as cancer therapy-related cardiovascular toxicity (CTR-CVT). CTR-CVT encompasses a broad spectrum of adverse cardiac effects, ranging from asymptomatic left ventricular systolic dysfunction to life-threatening heart failure, myocarditis, arrhythmias and ischaemic events. Early detection of cardiotoxicity is crucial to prevent irreversible cardiac damage and maintain patients' quality of life. Timely intervention may facilitate modifications in cancer treatment or the implementation of cardioprotective strategies to halt or reverse cardiac damage. Cardiac imaging in general-and echocardiography in particular-plays a pivotal role in achieving this goal by enabling clinicians to monitor, detect and manage cardiac dysfunction in patients with cancer. Improved survival rates have transformed many cancers into manageable chronic conditions. Cardiovascular disease is now a leading cause of morbidity and mortality among cancer survivors, emphasising the need for vigilant cardiovascular monitoring before, during and after cancer treatment. This review will focus on imaging tools and strategies in the detection of cardiotoxicity. We will explore conventional and emerging imaging modalities, highlighting their strengths, limitations and the evolving guidelines that shape clinical practice.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Negishi T, Miyazaki S, Park J, et al. Cardiac imaging in oncology: the detection of cardiotoxicity. Heart. 2025. PMID: 40998519. doi:10.1136/heartjnl-2024-323864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。